Image Sourced Mach7 Technologies Limited
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Mach7 Technologies (M7T) signs a contract renewal with Cabell Huntington Hospital in Huntington, West Virginia for a total value of $2.8 million
  • The agreement is for a five-year renewal of Cabell’s Enterprise Imaging Platform along with a five-year renewal on support for the eUnity Diagnostic Enterprise Viewer
  • This renewal converts the existing capital term licence agreement with Cabell to a five-year subscription-based agreement based on image volume
  • According to Mach7, subscription renewals on average have 20 per cent greater overall value than capital licence over the full term
  • Shares in Mach7 are up 3.09 per cent, trading at 50 cents at market close

Mach7 Technologies (M7T) has signed a contract renewal with Cabell Huntington Hospital in Huntington, West Virginia for a total value of $2.8 million.

The agreement is for a five-year renewal of Cabell’s Enterprise Imaging Platform along with a five-year renewal on support for the eUnity Diagnostic Enterprise Viewer.

This renewal converts the existing capital term licence agreement with Cabell to a five-year subscription-based agreement based on image volume.

Mach7 CEO Mike Lampron said the continued support from the company’s existing clients is pleasing.

“This long-term commitment shows the value that Mach7 brings to our clients across the
enterprise,” he said.

“The conversion from a capital model to a subscription model further shows a developing
trend that we are seeing in our business model.

“While this has an impact on the current reporting period, the revenue is contracted and will be recognised annually; overtime, showing greater value and revenue consistency on an annual basis.”

The company said the annual recurring revenue value will begin to recognised on a quarterly basis in the first quarter of the next fiscal year.

According to Mach7, subscription renewals on average have 20 per cent greater overall value than capital licence over the full term.

Shares in Mach7 were up 3.09 per cent, trading at 50 cents at market close.

M7T by the numbers
More From The Market Online

Patagonia shares rise 12% on lithium grades at maiden well in Argentina

Patagonia Lithium shares rise above 12 percent on lithium grading nearly 600 parts per million at…

Infini Resources gearing up for UAV geophys survey over Portland Creek

Infini Resources has announced its execution of an application for UAV-based geophysical surveys over its Portland…

Termites show Haranga the way to 8th uranium anomaly at Senegal’s Saraya

Haranga Resources finds 8th uranium anomaly at Senegal's Saraya through termite mound sampling, and is hoping…

BPH Energy renews NT Bonaparte Basin permit

BPH Energy (ASX:BPH) announced on Friday that it has renewed a key licence in the Northern…